The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Dupixent 300 mg/2 ml pens. The contract has a potential value of $9,737.94 and a performance period through March 8, 2024.
Amerisourcebergen Drug Corp, as the prime contractor, is responsible for providing this specialty pharmaceutical product to support military treatment programs and facilities. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA Troop Support Medical on behalf of the Department of Defense.
Generated 6/6/24, 9:52 AM